跳至主要内容
临床试验/NCT01484236
NCT01484236招募中不适用

National Lymphangioleiomyomatosis Registry, France

Vincent COTTIN2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
2
主要终点
Number of cases

研究概览

简要总结

RE-LAM-CE is a registry of lymphangioleiomyomatosis cases in France. its aim is to determine the incidence and prevalence of lymphangioleiomyomatosis in France, including demographic information and information concerning the timing and modalities of diagnosis.

Based on the registry, we will set up a prospective cohort of patients. The database will include detailed medical information, particularly regarding progression of the respiratory function.

详细描述

Lymphangioleiomyomatosis is a rare pulmonary disease occuring preferentially in women. Few data are available regarding the epidemiology of this disease, the frequency of the various forms with mild to moderate or severe disease, and the rapid or slow progression.

Several sources of information will be used in order to increase completeness. The registry will also allow to estimate the proportion of patients with lymphangioleiomyomatosis who are managed by the Reference Center and Competence Centers for rare lung diseases in France.

Data will be collected by a research assistant, and the study will be coordinated by the Pole IMER - Department of Public health and Epidemiology of HCL (Lyon Hospitals).

This study will provide a better knowledge on the natural course of the disease and the variability in severity and progression of lymphangioleiomyomatosis, and the applicability of diagnostic criteria proposed in 2009. This study will provide the first detailed epidemiological information on Lymphangioleiomyomatosis, will assess the management of this rare disease within the French National Plan for rare diseases 2005 - 2009, and will provide valuable medical information prior to the establishment of clinical trials

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with sporadic lymphangioleiomyomatosis or associated with Tuberous sclerosis.
  • patients diagnosed or hospitalized or seen in consultation since 01/01/2008

排除标准

  • 未提供

结局指标

主要结局

Number of cases

时间窗: 4 years

Determine incidence and prevalence of lymphangioleiomyomatosis.

次要结局

  • localisation of cases(4 years)
  • Progression-free survival(4 years)

研究者

发起方
Vincent COTTIN
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Vincent COTTIN

Professor V. Cottin

Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires

研究点 (2)

Loading locations...

相似试验